NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group

Leukemia. 2017 Apr;31(4):974-977. doi: 10.1038/leu.2016.361. Epub 2016 Nov 28.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / therapeutic use
  • Biomarkers, Tumor / genetics
  • Cyclophosphamide / therapeutic use
  • Cytarabine / therapeutic use
  • Daunorubicin / therapeutic use
  • Down-Regulation / genetics
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics*
  • Mercaptopurine / therapeutic use
  • Methotrexate / therapeutic use
  • Mutation / genetics
  • Nuclear Pore Complex Proteins / genetics*
  • Oncogene Proteins, Fusion / genetics
  • Prednisone / therapeutic use
  • Prognosis
  • Translocation, Genetic / genetics
  • Up-Regulation / genetics
  • Vincristine / therapeutic use

Substances

  • Biomarkers, Tumor
  • Nuclear Pore Complex Proteins
  • Nup98 protein, human
  • Oncogene Proteins, Fusion
  • Cytarabine
  • Vincristine
  • Cyclophosphamide
  • Mercaptopurine
  • Asparaginase
  • Prednisone
  • Methotrexate
  • Daunorubicin

Supplementary concepts

  • AIEOP acute lymphoblastic leukemia protocol